Tag: In the News

Hutton Recognized for Leadership as Biodesix Achieved Major Milestones in 2020   BOULDER, CO, February 2, 2021 – Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that Chief Executive Officer Scott Hutton was selected as the CEO of the Year, 2020 – The USA by…

 Important New Findings Validate Testing Strategies That Support Decision Making for Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC)  BOULDER, CO, January 26, 2021 – Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that three abstracts from multiple clinical studies will be featured at…

Initial program to focus on development of a companion diagnostic for HiberCell’s novel immunotherapy, Imprime PGG, to aid in patient selection across multiple oncology programs NEW YORK and BOULDER, CO, January 13, 2021 – HiberCell, a biotechnology company developing novel therapeutics for cancer relapse and metastasis, today announced an agreement with Biodesix, Inc. (Nasdaq: BDSX) to…

Record quarterly revenue driven by strength in COVID-19 testing and growth in lung diagnostic testing Boulder, CO,  January 8, 2021 – Biodesix, Inc., a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the company expects to report record fourth quarter 2020 preliminary unaudited revenue in a range of $25 million to…

WEST LAFAYETTE, Ind. – Purdue University is partnering with a Colorado company led by a Purdue alum to offer rapid antigen COVID-19 testing for undergraduate, graduate and professional students taking classes on the West Lafayette campus who will be living off campus (not in the residence halls or in Fraternity, Sorority and Cooperative Life housing)…

Boulder, CO,  January 5, 2021 – Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that Ryan Siurek has joined the company as Chief Accounting Officer reporting to Ms. Robin Harper Cowie, Chief Financial Officer. “I am very pleased to welcome Ryan as our new Chief…

Dr. Gerard A. Silvestri of Medical University of South Carolina Named Principal Investigator Boulder, CO, December 23, 2020 –Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, is proud to announce the launch and active recruitment of a first-in-class biomarker study aligned with the recommendations from the official 2018 American Thoracic Society (ATS) policy…

Findings Suggest Blood Collection Device Simplifies Specimen Collection and Transport While Maintaining Accuracy of Diagnostic Test Results Boulder, CO, December 15, 2020 – Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, today announced publication of a peer-reviewed study supporting its patented blood collection device (BCD). The device is designed to streamline whole blood…

Generates record quarterly revenue of $9.2 million Raises net proceeds of $63 million through initial public offering Adds to the significant and growing body of evidence demonstrating the clinical value of its portfolio of blood based diagnostic tests for lung disease Boulder, CO, December 10, 2020 –Biodesix, Inc. a leading data-driven diagnostic solutions company with a…

Assessment Confirms Test Performance After Two Years of Surveillance BOULDER, CO, October 28, 2020 – Biodesix, Inc. (Nasdaq: BDSX) a leading data-driven diagnostic solutions company with a focus in lung disease, today announced publication of an analysis of the company’s Nodify XL2® lung nodule test. The test supports clinical decision-making for suspicious nodules by more accurately…